Kirkland & Ellis LLP advised Pluralsight and Vista, while Latham & Watkins LLP represented A Cloud Guru in the transaction. Pluralsight, Inc., the technology workforce development...
Pluralsight’s Acquisition of A Cloud Guru
Clayton, Dubilier & Rice and KKR’s $5.3 Billion Acquisition of Cloudera
Latham & Watkins LLP represented Cloudera, Kirkland advised affiliates of Clayton, Dubilier & Rice and KKR, while Debevoise & Plimpton LLP advised Clayton, Dubilier & Rice...
Decarbonization Plus Acquisition Corporation II’s Business Combination with Tritium
Vinson & Elkins LLP and Clifford Chance advised Decarbonization Plus Acquisition Corporation II on the business combination with Tritium Holdings Pty Ltd, represented by Corrs Chambers...
Bright Machines’ Merger with SCVX
Willkie Farr & Gallagher LLP represented SCVX in the transaction, while Latham & Watkins LLP and Wolf Theiss represented Bright Machines. SCVX (NYSE: SCVX), a special...
Rain Therapeutics’ $125 Million Initial Public Offering
Latham & Watkins LLP represented the underwriters in the offering. Rain Therapeutics Inc. (Rain), a clinical-stage company developing precision oncology therapeutics, executed its initial public offering...
Treace Medical Concepts’ $106.3 Million Initial Public Offering
Latham & Watkins LLP represented Treace Medical Concepts, Inc. in the offering. Treace Medical Concepts, Inc. (Nasdaq: TMCI), a commercial-stage orthopaedic medical device company driving a...
Alkami Technology’s $180 Million Initial Public Offering
Latham & Watkins LLP represented Alkami in the offering, Davis Polk advised the representatives of the several underwriters. Alkami Technology, Inc., a leading cloud-based digital banking...
Reneo Pharmaceuticals’ $93.8 Million Initial Public Offering
Latham & Watkins LLP represents the underwriters in the offering while Wilson Sonsini Goodrich & Rosati advised Reneo Pharmaceuticals, Inc. Reneo Pharmaceuticals, Inc. has announced the pricing...
Design Therapeutics’s $276 Million Initial Public Offering
Latham & Watkins LLP represented the underwriters in the offering while Wilson Sonsini Goodrich & Rosati advised Design Therapeutics, Inc. Design Therapeutics, Inc. executed its initial public...
Airbnb’s $2 Billion Convertible Senior Notes Offering
Latham & Watkins LLP represented Airbnb in the offering. Airbnb, Inc. executed its offering of US$2 billion aggregate principal amount of 0% convertible senior notes due...
Hippo’s Merger with Reinvent Technology Partners Z
Latham & Watkins LLP acted as Hippo’s legal counsel, while Sullivan & Cromwell LLP served as Reinvent’s legal counsel for the transaction. Davis Polk advised the...
Angion Biomedica’s Initial Public Offering and Concurrent Private Placement
Latham & Watkins LLP represented Angion in the offering and private placement. Angion Biomedica Corp. (NASDAQ:ANGN) has announced the pricing of its initial public offering of 5...